SpikoGen® / Covax‑19
COVID‑19
CommercialApproved in Iran
Key Facts
About Vaxine
AI‑enhanced vaccine developer using the Advax™ adjuvant platform for infectious disease and immunotherapy.
View full company profileTherapeutic Areas
Other COVID‑19 Drugs
| Drug | Company | Phase |
|---|---|---|
| P-004 | Panacea Biotec | Phase 3 |
| FAVILOW | MSN Laboratories | Commercial |
| Movfor (Molnupiravir) | Hetero | Phase 3 |
| Nirmatrelvir/Ritonavir Generic | Hetero | Commercial |
| Oravax | Premas Biotech | Preclinical |
| SARS‑CoV‑2 Detection (TRURAPID®) | 3B BlackBio | Commercial |
| CPR‑COV‑001 | Chugai Pharmabody Research | Preclinical |
| Antroquinonol (Hocena) | Golden Biotechnology | Phase 1/2 |
| AdCOV‑19 | Adimmune | Phase 1/2 |